Cencora Inc. has experienced a series of events recently, crucially impacting its performance and stock value. It faced a
cyberattack, causing a significant data breach compromising Americans' health information. Despite this,
Walgreens Boots Alliance made a notable sale of about 1,859,390 Cencora shares.
Steven Collis, the CEO of Cencora, further influenced the market by selling 10,755 shares. This act had investors questioning since insider selling sometimes indicates a bearish outlook. However, despite a slight underperformance when compared to competitors, Cencora's stock price crossed above the
200 Day Moving Average of $221.11.
Earnings' reports suggest a relatively positive view, with Zacks Research and other analysts increasing EPS estimates and
Q2 earnings surpassing expectations. The company delivered
robust revenue growth and raised the financial outlook for 2024. Cencora completed a
$500 million senior notes offering, indicating a confident financial move.
The stock saw fluctuations reaching a 52-week high, and the major shareholder sold $399,991,976.80 in stock. Nevertheless, investors have shown interest in the company's earnings, with some encouraging retaining Cencora stock in their portfolio.
Cencora COR News Analytics from Wed, 30 Aug 2023 07:00:00 GMT to Sun, 26 May 2024 08:12:19 GMT -
Rating 5
- Innovation 3
- Information 6
- Rumor -1
